Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053047 · ClinicalTrials.gov registry record · NA
Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration
A NA study, sponsored by Bluedrop Medical Limited.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT06053047 is a NA study that was terminated before completion, run by Bluedrop Medical Limited. The registered enrollment target is 26 participants.
The verdict
NCT06053047, a NA study, was terminated before completion, sponsored by Bluedrop Medical Limited.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effects of the Bluedrop Monitoring System (BMS) on the development of diabetic foot ulcers. All Participants in this study will continue with their normal foot care and complete surveys with questions about their foot health every three months. Participants selected to receive the Bluedrop Monitoring System (BMS) will place it in their home and stand on it once a day for 12 months. Participants will also need to answer questions about their general foot health and, if using the system, their experience using the device and monitoring service.
Interventions
- DEVICE Bluedrop Monitoring Service (BMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2024-09-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06053047
The ClinicalTrials.gov registry entry for NCT06053047 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bluedrop Medical Limited, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bluedrop Monitoring Service (BMS) is the first listed.
NCT06053047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06053047 about?
NCT06053047 is a clinical study titled "Remote Monitoring of the Diabetic Foot to Prevent Re-Ulceration". The purpose of this study is to understand the effects of the Bluedrop Monitoring System (BMS) on the development of diabetic foot ulcers. All Participants in this study will continue with their normal foot care and complete surveys with questions about their foot health every three months. Partic...
What is the current status of trial NCT06053047?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2024-01-22. Estimated completion is 2024-09-18.
What interventions are being tested in trial NCT06053047?
The interventions under investigation include: Bluedrop Monitoring Service (BMS) (DEVICE).
Who is sponsoring clinical trial NCT06053047?
This trial is sponsored by Bluedrop Medical Limited, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.